Vial is a hyper scalable biotech — advancing programs into the clinic powered by dramatically lower cost trials and computationally designed therapeutics.
Investor insights
Funding rounds participated in
$67M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2020
Funding rounds raised
Total raised
$67M
from 2 investors over 1 rounds
V
Vial raised $67M on December 30, 2022
Investors: General Catalyst and + 11 Other investors